Immunoglobulin News and Research

RSS

$Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL$

Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL

Novartis announced today that the US Food and Drug Administration has approved Kymriah (tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, the first chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse.

30 Aug 2017

Pioneering cancer gene therapy gets green light — and $475,000 price tag

The country's first approved gene therapy — approved Wednesday to fight leukemia that resists standard therapies — will cost $475,000 for a one-time treatment, its manufacturer announced.

30 Aug 2017

Researchers develop new approach to efficiently produce versatile antibody therapies

A group of researchers has developed an approach to efficiently produce antibodies that can bind to two different target molecules simultaneously, a long-desired innovation in the field of cancer immunotherapy.

29 Aug 2017

Symptoms, triggers of food intolerance found to be similar in animals and humans

People are not the only ones suffering from the symptoms and problems of food intolerance and allergies.

23 Aug 2017

‘Breakthrough’ leukemia drug also portends ‘quantum leap’ in cost

When doctors talk about a new leukemia drug from Novartis, they ooze enthusiasm, using words like "breakthrough," "revolutionary" and "a watershed moment."

23 Aug 2017

Mice study reveals how natural killer cells in the placenta can cause miscarriages

Researchers at St. Michael's Hospital have identified how natural killer cells in the mouse placenta can cause a fetus to fail to grow in the womb or cause miscarriages.

9 Aug 2017

Omeros’ OMS721 receives orphan drug designation from FDA for treatment of IgA nephropathy

Omeros Corporation today announced that OMS721 has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of Immunoglobulin A (IgA) nephropathy.

4 Aug 2017

Researchers identify issues with current maternal CMV screening methods

Human cytomegalovirus (CMV) is a common virus found worldwide. When CMV infects fetuses, it can cause serious complications such as hearing difficulties and mental retardation in affected infants.

24 Jul 2017

Sialic acid found in animals protects farm children from asthma

It is a known fact that microbes on farms protect children from asthma and allergies. But even non-microbial molecules can have a protective effect: Immunologists from the University of Zurich have shown that a sialic acid found in farm animals is effective against inflammation of lung tissue.

6 Jul 2017

Researchers find new ways to create, deliver therapies for many immune-medicated neuropathies

Researchers at LSTM are looking at new ways to create and deliver medications for a wide range of immune-medicated neuropathies, by developing new synthetic versions of the treatment currently seen as the last resort option by doctors; intravenous immunoglobulin (IVIg) therapy.

6 Jul 2017

New tools can potentially play key role in early diagnosis of systemic sclerosis

The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference highlight the use of two new tools, which can potentially play a pivotal role in the early diagnosis of Systemic Sclerosis.

14 Jun 2017

Study emphasizes importance of molecule in maintaining balanced immune system in the gut

A healthy gut requires a molecule called gp96 to train the immune system to tolerate food and normal microbes, report researchers at the Medical University of South Carolina in the May 19, 2017 issue of Scientific Reports.

14 Jun 2017

When an insurer balks and treatment stops

Gillen Washington, a student at Northern Arizona University, had been getting medication for an immunodeficiency disease since 2011. But when he went to his clinic in November 2014 for the monthly dose, a nurse told him his insurance company had denied it.

7 Jun 2017

Researchers uncover structure of embryo-protecting protein

Revelations about a protein expressed in fetal cells could provide novel insights into its function and future immunosuppressive therapies.

10 May 2017

FARE announces recipients of 2017 Investigator in Food Allergy Awards

Food Allergy Research & Education, the world's largest private source of funding for food allergy research, is pleased to announce the recipients of the 2017 FARE Investigator in Food Allergy Awards after an extraordinarily competitive review process, with more than two dozen researchers submitting high-quality proposals.

22 Mar 2017

Immunoglobulin News and Research

Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL

Pioneering cancer gene therapy gets green light — and $475,000 price tag

Researchers develop new approach to efficiently produce versatile antibody therapies

Symptoms, triggers of food intolerance found to be similar in animals and humans

‘Breakthrough’ leukemia drug also portends ‘quantum leap’ in cost

Mice study reveals how natural killer cells in the placenta can cause miscarriages

Omeros’ OMS721 receives orphan drug designation from FDA for treatment of IgA nephropathy

Researchers identify issues with current maternal CMV screening methods

Sialic acid found in animals protects farm children from asthma

Researchers find new ways to create, deliver therapies for many immune-medicated neuropathies

New tools can potentially play key role in early diagnosis of systemic sclerosis

Study emphasizes importance of molecule in maintaining balanced immune system in the gut

When an insurer balks and treatment stops

Researchers uncover structure of embryo-protecting protein

FARE announces recipients of 2017 Investigator in Food Allergy Awards

ECDC guidance aims to improve antenatal screening for infections to avoid mother-to-child transmission

New study examines immune responses to Ebola vaccines at one year after immunization

Researchers uncover new genetic clues linked to autoimmune kidney disease

New absorption technique helps improve quality of life for people with allergic asthma

Researchers identify E. coli bacteria linking Crohn's disease to spondyloarthritis

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News